Xenon Pharmaceuticals XENE Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $5.55B.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's market capitalization?
- Xenon Pharmaceuticals (XENE) reported market capitalization of $5.55B in Q1 2026.
- How has Xenon Pharmaceuticals's market capitalization changed year-over-year?
- Xenon Pharmaceuticals's market capitalization increased by 116.1% year-over-year, from $2.57B to $5.55B.
- What is the long-term trend for Xenon Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's market capitalization has grown at a 34.3% compound annual growth rate (CAGR), from $793.44M to $3.46B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.